These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37899135)

  • 1. HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma.
    Shi K; Li QY; Zhang YQ; Huang H; Ding DX; Luo WM; Zhang J; Guo Q
    Aging (Albany NY); 2023 Oct; 15(20):11067-11091. PubMed ID: 37899135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma.
    Li QY; Guo Q; Luo WM; Luo XY; Ji YM; Xu LQ; Guo JL; Shi RS; Li F; Lin CY; Zhang J; Ke D
    Aging (Albany NY); 2024 Jan; 16(1):66-88. PubMed ID: 38170222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ncRNAs-mediated TIMELESS overexpression in lung adenocarcinoma correlates with reduced tumor immune cell infiltration and poor prognosis.
    Gao X; Tang M; Tian S; Li J; Wei S; Hua S; Liu W
    PLoS One; 2024; 19(1):e0296829. PubMed ID: 38261568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
    Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
    Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBA5 inhibition restricts lung adenocarcinoma via blocking macrophage M2 polarization and cisplatin resistance.
    Xu D; Zhang D; Wei W; Zhang C
    Exp Cell Res; 2024 Jul; 440(2):114148. PubMed ID: 38936760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NEAT1-miR-101-3p/miR-335-5p/miR-374a-3p/miR-628-5p-TRIM6 axis identified as the prognostic biomarker for lung adenocarcinoma via bioinformatics and meta-analysis.
    Ding DX; Li Q; Shi K; Li H; Guo Q; Zhang YQ
    Transl Cancer Res; 2021 Nov; 10(11):4870-4883. PubMed ID: 35116339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin.
    Wang Y; Zhang T; Du H; Yang M; Xie G; Liu T; Deng S; Yuan W; He S; Wu D; Xu Y
    Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37449493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and immune infiltrative biomarkers of CENPO in pan-cancer and its relationship with lung adenocarcinoma cell proliferation and metastasis.
    Wang Y; Ye D; Li Y; Lv F; Shen W; Li H; Tian L; Fan Z; Li Y; Wang Y; Li F; Chen Y
    BMC Cancer; 2023 Aug; 23(1):735. PubMed ID: 37558987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma.
    Wei S; Xing J; Lu K; Wang K; Yu W
    Hereditas; 2023 May; 160(1):27. PubMed ID: 37254219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
    Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
    Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.
    Chen R; Wang Z; Lu T; Liu Y; Ji Y; Yu Y; Tou F; Guo S
    Thorac Cancer; 2023 Apr; 14(10):893-912. PubMed ID: 36825773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.
    Yang W; Chen K; Yu Q; Liao R; He H; Peng Y; Yang Z; Zhang X
    Cancer Med; 2023 Jul; 12(13):14820-14832. PubMed ID: 37162299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.
    Chen M; Zhang S; Wang F; He J; Jiang W; Zhang L
    J Transl Med; 2024 Feb; 22(1):209. PubMed ID: 38414025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.